10-K Filing

ACUTUS MEDICAL, INC. CIK: 1522860 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001628280-22-007921`
Period End Date	20211231
Filing Date	20220330
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	afib-20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 42 Cash Flow Statement 98 Stockholders Equity 29

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	6,666.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.07M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities, short-term	`MarketableSecuritiesCurrent`	$76.70M	USD	Point-in-time
Marketable securities, short-term	`MarketableSecuritiesCurrent`	$105.84M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	6,666.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.16M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.63M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Inventory	`InventoryNet`	$12.96M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	27.99M	shares	Point-in-time
Inventory	`InventoryNet`	$16.41M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	27.96M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.33M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	27.99M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	27.96M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.05M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$151.39M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$126.29M	USD	Point-in-time
Marketable securities, long-term	`MarketableSecuritiesNoncurrent`	$8.73M	USD	Point-in-time
Marketable securities, long-term	`MarketableSecuritiesNoncurrent`	$7.12M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.36M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.67M	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$1.67M	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$4.52M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.01M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.65M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$717.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.15M	USD	Point-in-time
Total assets	`Assets`	$192.53M	USD	Point-in-time
Total assets	`Assets`	$169.79M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.52M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$9.10M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$7.31M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$5.40M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$1.50M	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$933.00K	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$395.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.51M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.91M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$4.59M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$1.13M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$39.01M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$40.41M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$3.90M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$500.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$50.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$65.95M	USD	Point-in-time
Total liabilities	`Liabilities`	$64.07M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized December 31, 2021 and 2020; 6,666 shares of preferred stock, designated as Series A Common Equivalent Preferred Stock, are issued and outstanding as of December 31, 2021, no shares issued and outstanding as of December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized December 31, 2021 and 2020; 6,666 shares of preferred stock, designated as Series A Common Equivalent Preferred Stock, are issued and outstanding as of December 31, 2021, no shares issued and outstanding as of December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of December 31, 2021 and 2020; 27,957,223 and 27,991,425 shares issued and outstanding as of December 31, 2021 and 2020, respectively	`CommonStockValue`	$28.00K	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of December 31, 2021 and 2020; 27,957,223 and 27,991,425 shares issued and outstanding as of December 31, 2021 and 2020, respectively	`CommonStockValue`	$28.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$487.29M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$584.61M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-361.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-478.70M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-217.00K	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$280.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$105.73M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$192.53M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$169.79M	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$8.46M	USD	Annual
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$17.26M	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$15.89M	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$32.92M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$36.68M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$33.45M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$50.36M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$63.52M	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$97.00K	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-3.75M	USD	Annual
Total costs and operating expenses	`OperatingCostsAndExpenses`	$129.38M	USD	Annual
Total costs and operating expenses	`OperatingCostsAndExpenses`	$99.80M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-112.12M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-91.33M	USD	Annual
Change in fair value of warrant liability	`ChangeInFairValueOfWarrantLiability`	$5.55M	USD	Annual
Change in fair value of warrant liability	`ChangeInFairValueOfWarrantLiability`	-	USD	Annual
Interest income	`InterestAndOtherIncome`	$436.00K	USD	Annual
Interest income	`InterestAndOtherIncome`	$116.00K	USD	Annual
Interest expense	`InterestExpense`	$5.51M	USD	Annual
Interest expense	`InterestExpense`	$5.68M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-10.62M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-5.56M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-117.68M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-101.96M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$23.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-101.98M	USD	Annual
Net loss	`NetIncomeLoss`	$-117.68M	USD	Annual
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-53.00K	USD	Annual
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-37.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-460.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$363.00K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-101.67M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-118.18M	USD	Annual
Net loss per common share, basic (in dollars per share)	`EarningsPerShareBasic`	$-4.11	USD	Annual
Net loss per common share, basic (in dollars per share)	`EarningsPerShareBasic`	$-8.94	USD	Annual
Net loss per common share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-4.11	USD	Annual
Net loss per common share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-8.94	USD	Annual
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	11.41M	shares	Annual
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	28.65M	shares	Annual
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.65M	shares	Annual
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.41M	shares	Annual

Cash Flow Statement 98 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-101.98M	USD	Annual
Net loss	`ProfitLoss`	$-117.68M	USD	Annual
Depreciation expense	`Depreciation`	$2.76M	USD	Annual
Depreciation expense	`Depreciation`	$5.75M	USD	Annual
AcQMap Systems converted to sales	`ChangeInPropertyPlantAndEquipmentConvertedToSales`	$-2.18M	USD	Annual
AcQMap Systems converted to sales	`ChangeInPropertyPlantAndEquipmentConvertedToSales`	-	USD	Annual
Sales-type lease loss	`SalesTypeLeaseSellingProfitLoss`	-	USD	Annual
Sales-type lease loss	`SalesTypeLeaseSellingProfitLoss`	$-28.00K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$457.00K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$640.00K	USD	Annual
Non-cash stock-based compensation expense	`ShareBasedCompensation`	$12.10M	USD	Annual
Non-cash stock-based compensation expense	`ShareBasedCompensation`	$13.75M	USD	Annual
Amortization of premiums/(accretion of discounts) on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-484.00K	USD	Annual
Amortization of premiums/(accretion of discounts) on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.28M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$767.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.40M	USD	Annual
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$684.00K	USD	Annual
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$496.00K	USD	Annual
Change in fair value of warrant liability	`ChangeInFairValueOfWarrantLiability`	$5.55M	USD	Annual
Change in fair value of warrant liability	`ChangeInFairValueOfWarrantLiability`	-	USD	Annual
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$97.00K	USD	Annual
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-3.75M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.90M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.47M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$3.89M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$3.87M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.13M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.38M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-304.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$622.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.28M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-871.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.55M	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.23M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-820.00K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-608.00K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$50.00K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-85.17M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-99.68M	USD	Annual
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$87.26M	USD	Annual
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$114.69M	USD	Annual
Sales of available-for-sale marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$8.59M	USD	Annual
Sales of available-for-sale marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$17.09M	USD	Annual
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$45.00M	USD	Annual
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$107.71M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.22M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.97M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-63.82M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$19.07M	USD	Annual
Payment of deferred offering costs	`PaymentsOfDebtExtinguishmentCosts`	$580.00K	USD	Annual
Payment of deferred offering costs	`PaymentsOfDebtExtinguishmentCosts`	-	USD	Annual
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$3.44M	USD	Annual
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.50M	USD	Annual
Payment of contingent consideration into escrow	`PaymentForContingentConsiderationLiabilityFinancingActivitiesPaidToEscrow`	-	USD	Annual
Payment of contingent consideration into escrow	`PaymentForContingentConsiderationLiabilityFinancingActivitiesPaidToEscrow`	$224.00K	USD	Annual
Proceeds from employee stock purchase plan	`ProceedsFromStockPlans`	$440.00K	USD	Annual
Proceeds from employee stock purchase plan	`ProceedsFromStockPlans`	-	USD	Annual
Proceeds from warrants exercises	`ProceedsFromWarrantExercises`	-	USD	Annual
Proceeds from warrants exercises	`ProceedsFromWarrantExercises`	$13.00K	USD	Annual
Proceeds from issuance of common stock, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$166.29M	USD	Annual
Proceeds from issuance of common stock, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$82.66M	USD	Annual
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$711.00K	USD	Annual
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$634.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$164.43M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$79.57M	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.00K	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-116.00K	USD	Annual
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$15.78M	USD	Annual
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.16M	USD	Annual
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$24.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$24.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$4.68M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$4.26M	USD	Annual
Issuance of Series D convertible preferred stock for Biotronik asset purchase	`IssuanceOfSeriesDConvertiblePreferredStockForBiotroniksAssetPurchase`	-	USD	Annual
Issuance of Series D convertible preferred stock for Biotronik asset purchase	`IssuanceOfSeriesDConvertiblePreferredStockForBiotroniksAssetPurchase`	$5.00M	USD	Annual
Issuance of Series D convertible preferred stock for Rhythm Xience Acquisition	`IssuanceOfSeriesDConvertiblePreferredStockForRhythmXienceAcquisition`	-	USD	Annual
Issuance of Series D convertible preferred stock for Rhythm Xience Acquisition	`IssuanceOfSeriesDConvertiblePreferredStockForRhythmXienceAcquisition`	$2.20M	USD	Annual
Change in unrealized loss on marketable securities	`DebtSecuritiesUnrealizedGainLoss`	$-53.00K	USD	Annual
Change in unrealized loss on marketable securities	`DebtSecuritiesUnrealizedGainLoss`	$-37.00K	USD	Annual
Right-of-use assets exchanged for operating lease liabilities	`RightofuseassetsExchangedForOperatingLeaseLiabilities`	$3.53M	USD	Annual
Right-of-use assets exchanged for operating lease liabilities	`RightofuseassetsExchangedForOperatingLeaseLiabilities`	-	USD	Annual
Accrued licensed intangibles assets	`AccruedLicensedIntangiblesAssets`	$2.00M	USD	Annual
Accrued licensed intangibles assets	`AccruedLicensedIntangiblesAssets`	-	USD	Annual
Change in unpaid purchases of property and equipment	`ChangeInUnpaidPurchasesOfPropertyPlantAndEquipment`	$101.00K	USD	Annual
Change in unpaid purchases of property and equipment	`ChangeInUnpaidPurchasesOfPropertyPlantAndEquipment`	$124.00K	USD	Annual
Unpaid deferred offering costs	`OfferingCostsIncurredButNotYetPaid`	$643.00K	USD	Annual
Unpaid deferred offering costs	`OfferingCostsIncurredButNotYetPaid`	-	USD	Annual
Net book value of AcQMap System sales-type leases	`SalesTypeLeaseNetInvestmentInLeaseNoncash`	-	USD	Annual
Net book value of AcQMap System sales-type leases	`SalesTypeLeaseNetInvestmentInLeaseNoncash`	$1.10M	USD	Annual
Conversion of convertible preferred stock into common stock upon IPO	`ConversionOfStockAmountConverted1`	-	USD	Annual
Conversion of convertible preferred stock into common stock upon IPO	`ConversionOfStockAmountConverted1`	$260.56M	USD	Annual
Reclassification of warrant liability to additional paid-in capital	`ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital`	-	USD	Annual
Reclassification of warrant liability to additional paid-in capital	`ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital`	$14.47M	USD	Annual

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Issuance costs	`PaymentsOfStockIssuanceCosts`	$5.89M	USD	Annual
Issuance costs	`PaymentsOfStockIssuanceCosts`	$16.36M	USD	Annual
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$105.73M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-53.00K	USD	Annual
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-37.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-460.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$363.00K	USD	Annual
Exchange of common stock for Series A Common Equivalent Preferred Stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$260.56M	USD	Annual
Exchange of common stock for Series A Common Equivalent Preferred Stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Issuance of common stock for cash, net of issuance costs of $16,361	`StockIssuedDuringPeriodValueIssuedForServices`	$166.29M	USD	Annual
Reclassification of warrant liability to stockholders' equity	`ReclassificationOfWarrantLiabilityToStockholdersEquity`	$14.47M	USD	Annual
Issuance of common stock for cash, net of issuance costs of $5,893 (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	6.33M	shares	Point-in-time
Issuance of common stock for cash, net of issuance costs of $5,893	`StockIssuedDuringPeriodValueNewIssues`	$82.66M	USD	Annual
Stock option exercises (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	172,312.00	shares	Annual
Stock option exercises (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	111,804.00	shares	Annual
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$711.00K	USD	Annual
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$634.00K	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$12.10M	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$13.52M	USD	Annual
Employee stock purchase plan shares issued	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$440.00K	USD	Annual
Warrant exercises	`StockIssuedDuringPeriodValueWarrantsExercised`	$13.00K	USD	Annual
Warrant exercises	`StockIssuedDuringPeriodValueWarrantsExercised`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-101.98M	USD	Annual
Net loss	`NetIncomeLoss`	$-117.68M	USD	Annual
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$105.73M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.